Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Pharmacogenomics J. 2014 Nov 25;15(4):310–315. doi: 10.1038/tpj.2014.69

Table 2.

Genetic variants of ADRA1A associated with sensitivity to phenylephrine (ED50)

SNP Caucasians African Americans All
ED50, ng/min, geometric mean
(95% CI)
P-value*
unadjust.
(adjusted)
ED50, ng/min, geometric mean
(95% CI)
P-value*
unadjust.
(adjusted)
P-value*
unadjust.
(adjusted)
0* 1 2 0* 1 2
rs574647 395 (248–627) 322 (201–514) 43 (5–360) 0.022 (0.064) 214 (131–350) 98 (46–208) 468 0.283 (0.039) 0.064 (0.008)
N = 28 N = 32 N = 4 N = 29 N = 11 N = 1

rs1079078 244 (156–381) 365 (199–671) 963 (593– 1565) 0.030 (0.055) 139 (85–230) 329 (162–667) 201 0.094 (0.082) 0.003 (0.011)
N = 38 N = 21 N = 5 N = 29 N = 11 N = 1

rs13270252 269 (186–398) 646 (316–1318) 324 0.108 (0.039) 186 (112–302) 204 (87–490) 35 (4–331) 0.207 (0.027) 0.586 (0.686)
N = 53 N = 10 N = 1 N = 21 N=14 N = 3

rs580739 394 (245–632) 241 (140–414) 336 (77–1468) 0.360 (0.623) 267 (172–416) 55 (32–93) 468 0.007 (0.005) 0.131 (0.103)
N = 29 N = 29 N = 6 N = 29 N = 11 N = 1
*

0, 1, 2 represent the number of variant alleles for each SNP.

N = number of subjects in each genotype group.

*

P values are before (unadjust.) and after adjustment for sex, BMI, baseline norepinephrine values and ethnicity (for analyses of the combined cohort).